Literature DB >> 7075672

Naloxone inhibits clomipramine in mouse forced swimming test.

J L Devoize, F Rigal, A Eschalier, J F Trolese.   

Abstract

Naloxone inhibited the effect of clomipramine on duration of immobility of mice in the forced swimming test. This test is proposed as an antidepressant study model. It had previously been shown that naloxone inhibited the analgesic effect of the antidepressant clomipramine. Several hypotheses are considered for the mechanism of the naloxone-clomipramine antagonism.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7075672     DOI： 10.1016/0014-2999(82)90241-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

Review 2.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Influence of naloxone on antidepressant drug effects in the forced swimming test in mice.

Authors:  J L Devoize; F Rigal; A Eschalier; J F Trolese; M Renoux
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Potentiation by TRH of the effect of imipramine on the forced-swimming test.

Authors:  V Reny-Palasse; R Rips
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

6.  Study of the clomipramine-morphine interaction in the forced swimming test in mice.

Authors:  A Eschalier; J Fialip; O Varoquaux; M C Makambila
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.